BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26758916)

  • 1. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.
    Hoban MD; Orkin SH; Bauer DE
    Blood; 2016 Feb; 127(7):839-48. PubMed ID: 26758916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Therapies for Sickle Cell Disease.
    Jayavaradhan R; Malik P
    Pediatr Clin North Am; 2018 Jun; 65(3):465-480. PubMed ID: 29803277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies.
    Magrin E; Miccio A; Cavazzana M
    Blood; 2019 Oct; 134(15):1203-1213. PubMed ID: 31467062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for sickle cell disease: moving from the bench to the bedside.
    Abraham AA; Tisdale JF
    Blood; 2021 Sep; 138(11):932-941. PubMed ID: 34232993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
    Dong AC; Rivella S
    Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene replacement therapy for sickle cell disease and other blood disorders.
    Townes TM
    Hematology Am Soc Hematol Educ Program; 2008; ():193-6. PubMed ID: 19074080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Genetic Therapy for Sickle Cell Disease.
    Orkin SH; Bauer DE
    Annu Rev Med; 2019 Jan; 70():257-271. PubMed ID: 30355263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
    Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
    Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major challenges for gene therapy of thalassemia and sickle cell disease.
    Papanikolaou E; Anagnou NP
    Curr Gene Ther; 2010 Oct; 10(5):404-12. PubMed ID: 20712578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease.
    Altrock PM; Brendel C; Renella R; Orkin SH; Williams DA; Michor F
    Am J Hematol; 2016 Sep; 91(9):931-7. PubMed ID: 27299299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for sickle cell disease: An update.
    Demirci S; Uchida N; Tisdale JF
    Cytotherapy; 2018 Jul; 20(7):899-910. PubMed ID: 29859773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer. A potential approach to gene therapy for sickle cell disease.
    Bank A; Markowitz D; Lerner N
    Ann N Y Acad Sci; 1989; 565():37-43. PubMed ID: 2672970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic therapies for sickle cell disease.
    Esrick EB; Bauer DE
    Semin Hematol; 2018 Apr; 55(2):76-86. PubMed ID: 29958563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell therapy for sickle cell disease: transplantation and gene therapy.
    Walters MC
    Hematology Am Soc Hematol Educ Program; 2005; ():66-73. PubMed ID: 16304361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle Cell Disease: From Genetics to Curative Approaches.
    Hardouin G; Magrin E; Corsia A; Cavazzana M; Miccio A; Semeraro M
    Annu Rev Genomics Hum Genet; 2023 Aug; 24():255-275. PubMed ID: 37624668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy as the New Frontier for Sickle Cell Disease.
    Garg H; Tatiossian KJ; Peppel K; Kato GJ; Herzog E
    Curr Med Chem; 2022; 29(3):453-466. PubMed ID: 34047257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse Approaches to Gene Therapy of Sickle Cell Disease.
    White SL; Hart K; Kohn DB
    Annu Rev Med; 2023 Jan; 74():473-487. PubMed ID: 36067800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.